Upon completion of this on-demand module, participants should be better able to:
- Discuss the clinical trials of prostate-specific antigen (PSA-based) screening.
- Describe a framework for prostate cancer screening, incorporating national guidelines.
- Identify modern diagnosis techniques, including the use of MRI for risk stratification and biopsy.
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Nebraska Medicine. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
1.0 Contact Hour Awarded
Nebraska Medicine is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
Faculty
The following faculty member has disclosed the following relationship:
- Benjamin A. Teply, MD
Researcher: BMS
Planning Committee
The following planning committee members have nothing to disclose:
- Michelle Grady, MHA
- Jacqueline Siebels, BSN, RN, NPD-BC
- Whitney Van Arsdall
